Epidemiologic studies based on self-reported physical activity (PA) show that higher levels of activ ity are associated with lower risk of incident COPD in smokers and in patients who already have COPD, and with lower risk of acute exacerbations, hospital admissions, and mortality. 1-3 A recent, 4-year, prospective study of patients with COPD showed that objectively measured PA was the best predictor of all-cause mortality compared with a broad range of other prognostic factors, including airfl ow obstruction, exercise performance, cardiovascular status, nutritional and muscular status, systemic infl ammation, health status, depressive symptoms, and dyspnea. Each increase of 1,845 steps per day was associated with a 51% lower risk of death. 4 Objective measures of PA capture what patients actually do vs what they report doing or are capable of doing during a laboratory test. 5 Findings from these studies underscore the critical importance of PA in COPD and the need to better understand how modifi able factors such as psychologic well-being infl uence PA.The prevalence of major depression in patients with moderate to severe COPD is approximately 40%. 6 Nearly 20% of patients had episodes of moderate to severe depression prior to their COPD diagnosis. 7 Anxiety disorders, which have considerable overlap Background: Physical activity (PA) has been found to be an excellent predictor of mortality beyond traditional measures in COPD. We aimed to determine the association between depression and anxiety with accelerometry-based PA in patients with COPD. Methods: We performed a cross-sectional analysis of baseline data from 148 stable patients with COPD enrolled in an ongoing, longitudinal, observational study. We measured PA (total daily step count) with a Stepwatch Activity Monitor over 7 days, depression and anxiety with the Hospital Anxiety and Depression Scales (HADSs), dyspnea with the Shortness of Breath Questionnaire, and functional capacity with the 6-min walk test. Results: Increased anxiety was associated with higher levels of PA such that for every one-point increase in the HADS-Anxiety score there was a corresponding increase of 288 step counts per day ( b 5 288 steps, P , .001), after adjusting for all other variables. Higher levels of depressive symptoms were associated with lower PA ( b 5 2 176 steps, P 5 .02) only when anxiety was in the model. The interaction term for anxiety and depression approached signifi cance ( b 5 26, P 5 .10), suggesting that higher levels of anxiety mitigate the negative effects of depression on PA.
Conclusions:The increased PA associated with anxiety in COPD is, to our knowledge, a novel fi nding. However, it is unclear whether anxious patients with COPD are more restless, and use increased psychomotor activity as a coping mechanism, or whether those with COPD who push themselves to be more physically active experience more anxiety symptoms. Future studies should evaluate for anxiety and PA to better inform how to improve clinical outcomes.